Hirvonen J Goodwin RS Li CT et al.: Reversible and regionally selective down regulation of brain cannabinoid pronunciation cannabinoid CB(1) receptors in chronic daily cannabis smokers. Molecular Psychiatry 2012; 17 642-49 MEDLINE e117. Cannabis Oil In Texas kurzthaler I Bodner T Kemmler G et al.: The effect of nabilone on neuropsychological functions related to driving ability: an extended case series. Hum Psychopharmacol 2005; 20: 291-3.
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br buy cbd oil in texas J Clin Pharmacol 2010; 70: 656-63. MEDLINE e36. Ahmedzai S Carlyle DL Clader IT Moran F: Anti-emetic Cannabis Oil In Texas efficacy and toxicity of nabilone a synthetic cannabinoid in lung cancer chemotherapy.
Grotenhermen F: Cannabinoids. Curr Drug Targets CNS Neurol Disord 2005; 4: 507-30. cannabidiol dose epilepsy CrossRef MEDLINE 11.
Arch Kriminol 2007; 220: 11-9 MEDLINE nova-Institut GmbH Chemiepark Knapsack Hürth: Dr. med. Grotenhermen Klinik für Psychiatrie
Sozialpsychiatrie und cannabidiol oil recipe Psychotherapie Medizinische Hochschule Hannover: Prof.
Niiranen Aila Mattson K: A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy. Am J Clin Oncol 1985; 8: 336-40. CrossRef MEDLINE e50.
MEDLINE e42. e43. Herman TS Einhorn LH Jones SE et al.: Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med 1979; 300: 1295-7.
CrossRef MEDLINE e10. Collin C Davies P Mutiboko IK Ratcliffe S for the Sativex Spasticity in MS Study Group: Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurology 2007; 14: 290-6. MEDLINE e11. Conte A Bettolo CM Onesti E et al.: Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis. Eur J Pain 2009; 13: 472-7.
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study. Psychopharmacology 2010; 212: 675-86. MEDLINE e63. Abrams DI Hilton JF Leiser RJ et al.: Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized placebo-controlled clinical trial. Ann Intern Med 2003; 139: 258-66. MEDLINE e64. Haney M Rabkin J Gunderson E Foltin RW: Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and how to make hash oil for vape mood.
Zajicek JP Sanders HP Wright DE et al.: Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1664-9. MEDLINE e7. Vaney C Heinzel-Gutenbrunner M Jobin P et al.: Efficacy safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized double-blind placebo-controlled crossover study. Multiple Sclerosis 2004; 10: 417-24. MEDLINE e8. Wade DT Makela P Robson P House H Bateman C: Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind randomized placebo-controlled study on 160 patients.